Markets:

Overview

News

Currencies

International

Treasuries

10x Genomics, Inc. - Common Stock (NQ:TXG)

97.42 +3.92 (+4.19%)

Delayed Quote Updated: 3:28 PM EDT, Oct 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about 10x Genomics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

13 14 Next >

Ray Dalio's Bridgewater Cuts Stake In Microsoft Stock By 20% – Is Big Tech Losing Its Shine? ↗

November 14, 2024

Ray Dalio's Bridgewaterand Ark Invest trimmed their Microsoft positions, signaling a shift in Big Tech's role in portfolios.

Via Benzinga

Cathie Wood's Ark Innovation, Genomic ETFs Celebrate 10 Years: How Annual Returns Stack Up Against S&P 500 ↗

October 31, 2024

The Ark Innovation and Ark Genomic ETFs turn ten years old. A look at the annual returns and current top holdings.

Via Benzinga

Topics ETFs Stocks

These Analysts Boost Their Forecasts On 10x Genomics After Q3 Results ↗

October 30, 2024

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

October 29, 2024

Via Benzinga

Looking Into 10x Genomics's Recent Short Interest ↗

October 17, 2024

Via Benzinga

Where 10x Genomics Stands With Analysts ↗

October 10, 2024

Via Benzinga

In-Depth Examination Of 11 Analyst Recommendations For 10x Genomics ↗

September 03, 2024

Via Benzinga

S&P Moves Lower; Domino's Pizza Posts Mixed Q3 Results ↗

October 10, 2024

Via Benzinga

Topics Stocks

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

October 10, 2024

Via Benzinga

Crude Oil Surges 3%; Delta Air Lines Posts Downbeat Earnings ↗

October 10, 2024

Via Benzinga

Dow Falls Over 100 Points; US Inflation Rate Slows To 2.4% In September ↗

October 10, 2024

Via Benzinga

Topics Economy Stocks

10x Genomics Crashes After 'Disruptive' Reorg Upsets Third-Quarter Sales ↗

October 10, 2024

The company is undergoing a reorganization that has proven more "disruptive" than previously expected.

Via Investor's Business Daily

Navigating 11 Analyst Ratings For 10x Genomics ↗

August 13, 2024

Via Benzinga

12 Analysts Assess 10x Genomics: What You Need To Know ↗

July 16, 2024

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

October 10, 2024

Via Benzinga

Gene Sequencing Tech Provider 10x Genomics' Q3 Sales Fall Short On Expectations, But CEO Sees Opportunity Ahead ↗

October 10, 2024

10x Genomics reported Q3 2024 revenue of $151.7 million, down 1% from last year. Instruments revenue dropped 46%, while consumables grew 10%. CEO Serge Saxonov acknowledged the challenges faced but...

Via Benzinga

Nasdaq, S&P 500 Futures Slip As September CPI Data Looms, Tesla On Radar Ahead Of Robotaxi Event: Strategist Offers Stock Tips Aligned With Presidential Candidates' Trade Policies ↗

October 10, 2024

The imminent release of the September consumer price inflation report is keeping sentiment guarded as the index futures trade modestly lower early Thursday.

Via Benzinga

Topics Economy Stocks

Why BloomZ Shares Are Trading Higher By Around 64%; Here Are 20 Stocks Moving Premarket ↗

October 10, 2024

Via Benzinga

Delta Air Lines, Domino's Pizza And 3 Stocks To Watch Heading Into Thursday ↗

October 10, 2024

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

October 09, 2024

Via Benzinga

Gold Rally Loses Steam As Treasury Yields Stabilize, Dollar Rebounds: 6 Miner Stocks See Declines On Wednesday ↗

August 28, 2024

Gold rally loses momentum as dollar rebounds and Treasury yields stabilize. Gold mining stocks also decline due to dip in gold prices.

Via Benzinga

Cisco Posts Upbeat Earnings, Joins Tesla, Ulta Beauty, Robinhood, Dell And Other Big Stocks Moving Higher On Thursday ↗

August 15, 2024

Via Benzinga

Starbucks To Rally Around 43%? Here Are 10 Top Analyst Forecasts For Tuesday ↗

August 13, 2024

Via Benzinga

TXG Stock Earnings: 10x Genomics Beats EPS, Beats Revenue for Q2 2024 ↗

August 08, 2024

TXG stock results show that 10x Genomics beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.

Via InvestorPlace

Cathie Wood-Led Ark Invest Sells $8M In Tesla Shares Despite Bullish Autonomy Forecast ↗

July 18, 2024

Via Benzinga

Strategic Buy Lights Up This Biotech Stock: Time to Invest?

July 16, 2024

Life sciences company Illumina Inc. (NASDAQ: ILMN) stock surged over 10% following its announcement of the acquisition of Fluent Biosciences.

Via MarketBeat

Cathie Wood Touts Palantir, Coinbase And Roku As ARK's Flagship Fund Shifts Focus From Mag 6 Amid 'Whiff' Of Lower Interest Rates ↗

July 11, 2024

In a recent letter to investors, Cathie Wood, the CEO of ARK Invest, highlighted the potential of the company's flagship fund, ARK Innovation ETF, despite its recent underperformance.

Via Benzinga

Topics ETFs

What's Going On With 10x Genomics Stock On Wednesday? ↗

July 10, 2024

Illumina acquires Fluent BioSciences to enhance single-cell analysis and multiomics research. 10x Genomics faces challenges as shares drop amid competitive pricing pressures in the single-cell market.

Via Benzinga

Why SeaStar Medical Holding Shares Are Trading Lower By Around 34%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

July 10, 2024

Via Benzinga

Kura Sushi Posts Weak Q3 Results, Joins LegalZoom.com And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session ↗

July 10, 2024

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9

...

13 14 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

10x Genomics, Inc. - Common Stock (NQ:TXG)

All News about 10x Genomics, Inc. - Common Stock

Starting at /week.